Short answers, pulled from the story.
Editors officially adopted the current name Alcohol: Clinical & Experimental Research in 2023. This shift marked a deliberate move away from older stigmatizing language toward more precise clinical descriptions.
Wiley-Blackwell serves as the primary publisher on behalf of the Research Society on Alcoholism and the International Society for Biomedical Research on Alcoholism. These societies provide the editorial oversight necessary to maintain high scientific standards across all issues.
Major platforms include MEDLINE, Scopus, Embase, BIOSIS Previews, CAB HEALTH, Psychological Abstracts/PsycINFO, Science Citation Index, and Current Contents. The presence in these aggregations means that findings appear in search results used by hospitals, universities, and government agencies worldwide.
The 2020 impact factor score reached 3.455 according to Journal Citation Reports data. Within the category labeled Substance Abuse, the publication ranked 12th out of 21 competing titles.
Articles focus specifically on alcohol abuse and methods designed to treat the condition including experimental data from laboratory settings and clinical observations from patient care environments. The scope excludes non-alcohol substances unless they directly relate to ethanol consumption patterns.